Actively Recruiting
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)
Led by Hui-Sheng Chen · Updated on 2025-08-21
30
Participants Needed
1
Research Sites
286 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To explore the safety and feasibility of intra-arterial neuroprotective strategy in acute ischemic stroke patients who received recanalization operation.
CONDITIONS
Official Title
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Acute ischemic stroke patients eligible for endovascular treatment
- Signed informed consent
You will not qualify if you...
- Modified Rankin Score greater than 2 caused by prior stroke
- Coagulation disorders, bleeding tendency, or platelet count less than 80,000/mm3
- Severe liver or kidney dysfunction, elevated liver enzymes or creatinine, or dialysis requirement
- Severe hypertension with systolic over 200 mmHg or diastolic over 110 mmHg
- Deemed unsuitable for the study by the researcher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Neurology, General Hospital of Northern Theater Command
Shenyang, China, 110016
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here